Matthew Paul Spindler, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestines | 1 | 2023 | 1912 | 0.450 |
Why?
|
| Smoking Cessation | 1 | 2021 | 2079 | 0.340 |
Why?
|
| Immunoglobulin A | 3 | 2024 | 990 | 0.260 |
Why?
|
| Tritrichomonas | 1 | 2024 | 4 | 0.250 |
Why?
|
| Intestinal Mucosa | 3 | 2024 | 3048 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2020 | 3440 | 0.210 |
Why?
|
| Bacteria | 2 | 2023 | 2226 | 0.190 |
Why?
|
| Immunity, Mucosal | 2 | 2024 | 494 | 0.190 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2022 | 348 | 0.170 |
Why?
|
| Mucous Membrane | 1 | 2023 | 660 | 0.170 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2020 | 152 | 0.160 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 258 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2022 | 586 | 0.160 |
Why?
|
| Nasopharynx | 1 | 2021 | 420 | 0.150 |
Why?
|
| Feces | 2 | 2021 | 1515 | 0.140 |
Why?
|
| Autoimmunity | 3 | 2020 | 1361 | 0.140 |
Why?
|
| Insulin-Secreting Cells | 2 | 2020 | 900 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2020 | 798 | 0.110 |
Why?
|
| Immunity, Innate | 2 | 2022 | 3080 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2023 | 4419 | 0.100 |
Why?
|
| RNA, Viral | 1 | 2021 | 2865 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 1207 | 0.100 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2015 | 475 | 0.100 |
Why?
|
| Weight Gain | 1 | 2021 | 2357 | 0.090 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 823 | 0.080 |
Why?
|
| New York City | 2 | 2021 | 738 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 1969 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 3108 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 2444 | 0.060 |
Why?
|
| Mice | 5 | 2024 | 82045 | 0.060 |
Why?
|
| Phenotype | 1 | 2023 | 16712 | 0.060 |
Why?
|
| Smoking | 1 | 2021 | 9099 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2017 | 6429 | 0.060 |
Why?
|
| Health Behavior | 1 | 2015 | 2649 | 0.050 |
Why?
|
| Animals | 7 | 2024 | 169418 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Symbiosis | 1 | 2024 | 297 | 0.050 |
Why?
|
| Germinal Center | 1 | 2024 | 379 | 0.050 |
Why?
|
| Cytokines | 3 | 2021 | 7449 | 0.050 |
Why?
|
| Hybridomas | 1 | 2022 | 444 | 0.050 |
Why?
|
| Plasma Cells | 1 | 2024 | 598 | 0.050 |
Why?
|
| Glutathione Disulfide | 1 | 2020 | 32 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2020 | 129 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 4781 | 0.040 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2020 | 112 | 0.040 |
Why?
|
| Humans | 11 | 2023 | 768451 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2024 | 998 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2024 | 977 | 0.040 |
Why?
|
| Italy | 1 | 2021 | 853 | 0.040 |
Why?
|
| Clone Cells | 1 | 2022 | 1672 | 0.040 |
Why?
|
| Glutathione | 1 | 2020 | 587 | 0.040 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2017 | 37 | 0.040 |
Why?
|
| Chemokines | 1 | 2020 | 963 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2020 | 833 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 22365 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2020 | 1375 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1797 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1625 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2020 | 5042 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1465 | 0.020 |
Why?
|
| Colon | 1 | 2020 | 1804 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2020 | 2611 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1892 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2150 | 0.020 |
Why?
|
| Colitis | 1 | 2020 | 1244 | 0.020 |
Why?
|
| Viral Load | 1 | 2021 | 3399 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 1855 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2016 | 1349 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 1362 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2020 | 5904 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2020 | 2293 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 11138 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4642 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2021 | 19041 | 0.020 |
Why?
|
| Female | 5 | 2021 | 396943 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22293 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9687 | 0.010 |
Why?
|
| Caregivers | 1 | 2015 | 2302 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10273 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 74915 | 0.010 |
Why?
|
| Male | 4 | 2021 | 364781 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18388 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13324 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10865 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 30028 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8753 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24311 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18478 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41797 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 171520 | 0.010 |
Why?
|
| Adolescent | 2 | 2017 | 89168 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 223418 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59680 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 26351 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 60045 | 0.000 |
Why?
|
| Child | 1 | 2015 | 80863 | 0.000 |
Why?
|
| Adult | 1 | 2015 | 223542 | 0.000 |
Why?
|